Literature DB >> 10028311

Summary of a workshop on potency and dosage of von Willebrand factor concentrates.

A C Chang1, M E Rick, L Ross Pierce, M J Weinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10028311     DOI： 10.1046/j.1365-2516.1998.0040s3001.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  5 in total

Review 1.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

2.  Evaluation of the effect of 6 von Willebrand factor concentrates on platelet adhesion to human vein segments under flow conditions.

Authors:  Wolfgang Mouton; Jerzy Madon; Joerg Fehr; Thomas Bombeli
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

3.  Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

Authors: 
Journal:  P T       Date:  2010-01

4.  Von Willebrand Disease and Pregnancy.

Authors:  Muhammad Wasif Saif; Carmen Allegra
Journal:  Consultant       Date:  2001-03

5.  Von Willebrand disease: an overview.

Authors:  K Pavani Bharati; U Ram Prashanth
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.